More than a quarter of solid-organ transplant recipients are traveling to foreign regions where there are greater health risks than their home country. There may be higher risk of complications from typical travel-related illnesses and risk of opportunistic infections not faced by healthy travelers. Some vaccinations may be contraindicated after solid-organ transplant, and those that are safe may have decreased efficacy. Drug interactions between antirejection regimens and medications for malaria prophylaxis and traveler�s diarrhea must be considered. This article discusses how providers can best advise and help protect these high-risk travelers.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados